Skip to Main text


Press Release 2021:


Nitto Avecia Announces Major Facility Renovation Project

MILFORD, MA — Nitto Avecia Inc. (Avecia) announced today a major facility renovation project to expand the company’s analytical development and process development capacity. These new state-of-the-art Analytical and Process Development laboratories will enable an increase in existing Process Development operations by 70% and returns the Analytical Development laboratories, currently located in Marlborough, back to the main Milford site. The Process Development laboratories, currently at the Milford Site, will be relocated to a newly renovated space under the same roof as the Analytical Development laboratories, continuing to strengthen and grow the synergistic relationship across the two groups. The renovation will provide space for close to 100 new employees, including new offices, collaboration spaces, and conference rooms allowing the relocation of all existing employees and equipment from the two sites as well as space to expand capabilities. In anticipation of increased stability sample demand at the Milford site, the new design plan will incorporate additional Quality Control Stability capabilities in the future as well. Finally, with the increase in the number of Personalized Medicine opportunities, a dedicated Personalized Medicines Room will be added to support the development of products intended to treat a single patient and a specific indication. The renovations and transitions are currently underway, with the new Analytical and Process Development laboratories expected to be fully operational December 2021. The expanded capacity will create many new full-time positions over the next several months that will specialize in analytical chemistry, process development chemistry, and manufacturing. More information on open positions at any of the Avecia facilities may be found at

About Nitto Avecia Inc:

Nitto Avecia Inc. is a recognized leader in therapeutic nucleic acid manufacturing and development services with facilities located in Milford, Mass.; Marlboro, Mass.; and Cincinnati offering services for DNA, RNA and other oligonucleotides-based therapeutics from milligram scale at pre-clinical stage to 1000 kg + post commercial launch. More information: Nitto Avecia is a proud member of Nitto Group. More information:


Nitto Avecia Pharma Services is your single solution for premier contract development and manufacturing services. Nitto Avecia Pharma Services supports the pharmaceutical, biopharmaceutical, and medical device industries with a complete package of cGMP services including preformulation/formulation, parenteral manufacturing, analytical development, biopharmaceutical development, structural chemistry, analytical chemistry, microbiology, stability storage and drug delivery device testing. With three state-of-the-art facilities located on one campus in Irvine, CA, Nitto Avecia Pharma Services’ experienced staff and robust quality infrastructure delivers client-centric solutions for early phase through post-market life cycle management. Learn more at


Tammy Cooper
VP of Business Development
Nitto Avecia Inc. & Nitto Avecia Pharma Services Inc.
(619) 278-1555

Contact Us

For any inquiries about this press release.

Business Hours (EST)
8:00 a.m.-5:30 p.m.(Except for Sat, Sun, and Holidays)

Here is the information at the release day. This information may be different from the information at other medias. Please be forewarned.

Back to Page Top